Melissa Creary

Illustration of the University of Michigan School of Public Health

On the Heights: November 2025

November highlights include a National Academies leadership role, new research on AI adoption in healthcare and youth mental health reporting systems, faculty testimony on medical debt relief, and a new podcast series.

Photo of Melissa Creary

Gene-editing treatments for sickle cell disease may be out of reach for many

Q&A with Melissa Creary

Federal approval of a breakthrough gene-editing technology that treats the pain and debilitating effects of sickle cell disease is cause for celebration among a community with few options for relief, but it also comes with concerns that too few people can afford to pay for the therapy.

racism in healthcare

Structural Racism Is Not an Exemption from Accountability

In February 2021, the Journal of the American Medical Association (JAMA) tweeted, “No physician is racist, so how can there be structural racism in health care?” The tweet was designed to promote a podcast that was ostensibly focused on structural racism yet did not include experts on the topic. The subsequent uproar highlighted the harm caused by deep intentional ignorance of the term structural racism, defined in the American Journal of Public Health as “policies and practices…that confer advantages on people considered White and ideologies that maintain these advantages, while simultaneously oppressing other racialized groups.”